Credit Suisse reiterated coverage on 23andMe Holding with a new price target

2/11/22 8:14:04 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Credit Suisse reiterated coverage of 23andMe Holding with a rating of Outperform and set a new price target of $11.00 from $14.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ME

Date	Price Target	Rating	Analyst
11/29/2022	$7.00	Buy	Berenberg
9/22/2022	$6.00	Outperform	Cowen
2/11/2022	$14.00 → $11.00	Outperform	Credit Suisse
12/20/2021	$13.00 → $9.00	Neutral	Citigroup
11/15/2021	$12.00 → $13.00	Buy → Neutral	Citigroup
11/11/2021	$13.00 → $14.00	Outperform	Credit Suisse
8/17/2021	$13.00	Outperform	Credit Suisse
7/12/2021	$14.00	Buy	Citigroup